¡ãÁ¦56ȸ À¯ÇÑÀÇÇлó ¼ö»óÀÚ.<»çÁø ¿ÞÂʺÎÅÍ ¹Ú¸íÇÏ ¼¿ï½ÃÀÇ»çȸÀå, ÃÖ»óÇö ¿ï»êÀÇ´ë Á¶±³¼ö(ÀþÀºÀÇÇÐÀÚ»ó), ÃÖÁØ¿ë ¿¬¼¼ÀÇ´ë ±³¼ö(´ë»ó), °íÁØ¿µ Ã¥ÀÓ¿¬±¸¿ø(ÀþÀºÀÇÇÐÀÚ»ó), Á¶¿íÁ¦ À¯ÇѾçÇà ´ëÇ¥ÀÌ»ç »çÀå>
À¯ÇѾçÇà(´ëÇ¥ÀÌ»ç »çÀå Á¶¿íÁ¦)¿Í ¼¿ïƯº°½ÃÀÇ»çȸ(ȸÀå ¹Ú¸íÇÏ)´Â 17ÀÏ ¿ÀÈÄ 7½Ã Á¶¼±È£ÅÚ ±×·£µåº¼·ë¿¡¼ ÀÇ»ç½Å¹® â°£ 63Áֳ⠱â³ä½Ä ¹× Á¦56ȸ À¯ÇÑÀÇÇлó ½Ã»ó½ÄÀ» °³ÃÖÇß´Ù.
Á¦56ȸ À¯ÇÑÀÇÇÐ»ó¡¯ ´ë»ó¿¡´Â ÃÖÁØ¿ë ¿¬¼¼ÀÇ´ë ³»°úÇб³½Ç ±³¼ö(¼¼ºê¶õ½ºº´¿ø)°¡ Â÷ÁöÇßÀ¸¸ç ÀþÀºÀÇÇÐÀÚ»ó¿¡´Â ÃÖ»óÇö ¿ï»êÀÇ´ë ¿µ»óÀÇÇб³½Ç Á¶±³¼ö(¼¿ï¾Æ»êº´¿ø)¿Í °íÁØ¿µ Áö³ðÀλçÀÌÆ®Å×Å©³î·ÎÁö Ã¥ÀÓ¿¬±¸¿øÀÌ °¢°¢ ¼ö»óÇß´Ù.
ÃÖÁØ¿ë ±³¼ö´Â 'Lancet Microbe'¿¡ 'Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults'¶ó´Â Á¦¸ñÀÇ ³í¹®À», ÃÖ»óÇö Á¶±³¼ö´Â 'Radiology'¿¡ 'Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI'¸¦, °íÁØ¿µ Ã¥ÀÓ¿¬±¸¿øÀº 'Journal of hepatology'¿¡ 'Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner'ÀÇ ³í¹®À¸·Î °¢°¢ ¼±Á¤µÆ´Ù.
¼¿ïƯº°½ÃÀÇ»çȸ ½É»çÀ§´Â ƯÈ÷ À̹ø ½É»ç¿¡¼ ³»°ú°è, ¿Ü°ú°è, ±âÃÊÀÇÇÐ ¹× Áö¿ø°ú ºÐ¾ß µî °¢ °ú¸¦ °í·ÁÇÏ¿© ¼ö»óÀÚ¸¦ ¼±Á¤ÇÔÀ¸·Î½á Àü¹ÝÀûÀÎ ÀÇÇйßÀüÀ» µµ¸ðÇßÀ¸¸ç ¾ÕÀ¸·Îµµ ÀÇÇйßÀüÀÇ ¿¬±¸¿¡ ³ë·ÂÇÏ´Â ¸¹Àº ºÐµéÀÌ À¯ÇÑÀÇÇлóÀÇ ¼ö»ó ±âȸ¸¦ °¡Áú ¼ö ÀÖµµ·Ï Àû±Ø ³ë·ÂÇÒ °ÍÀÓÀ» ¹àÇû´Ù.
±¹³» ÀÇÇÐÀÚµéÀÇ ³ôÀº ¿¬±¸¿ °íÃë¿Í ¹Ì·¡ ÁöÇâÀû ÁÂÇ¥¸¦ ¸¶·ÃÇϱâ À§ÇÏ¿© Áö³ 1967³â¿¡ Á¦Á¤µÈ À¯ÇÑÀÇÇлóÀº ÁÖ½Äȸ»ç À¯ÇѾçÇàÀÌ ÈÄ¿øÇÏ°í ÀÖ´Ù. ¿ÃÇØ·Î Á¦56ȸ¸¦ ¸ÂÀÌÇÔ¿¡ µû¶ó ¿ì¸®³ª¶ó¿¡¼ ¿À·£ ¿ª»ç¸¦ ÀÚ¶ûÇÏ´Â ÀÇÇлóÀ¸·Î Çѱ¹ ÀÇÇÐ ¹ßÀü¿¡µµ Å« ±â¿©¸¦ ÇÏ°í ÀÖ´Â °ÍÀ¸·Î Æò°¡¹Þ°í ÀÖ´Ù.
´ë»ó ¼ö»óÀÚ¿¡°Ô´Â 5000¸¸¿ø, ÀþÀºÀÇÇÐÀÚ»ó ¼ö»óÀÚ¿¡°Ô´Â °¢°¢ 1500¸¸¿øÀÇ »ó±ÝÀ» ¼ö¿©Çß´Ù.